✦ LIBER ✦

Progress on the treatment of chronic hepatitis C

✍ Scribed by Mary Beth Nierengarten

Book ID: 117789536
Publisher: The Lancet
Year: 2003
Tongue: English
Weight: 44 KB
Volume: 3
Category: Article
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(03)00844-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of steatosis on disease progr

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

✍ Heather M Patton; Keyur Patel; Cynthia Behling; David Bylund; Lawrence M Blatt; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Modeling the impact of interferon alfa t

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view

✍ Rodolphe Sobesky*; †; Philippe Mathurin*; †; Frederic Charlotte§; Joseph Moussal 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Treatment for chronic hepatitis C

✍ Bruce R. Bacon 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 104 KB

Progress in the prevention and treatment

Progress in the prevention and treatment of chronic viral hepatitis

📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Interferon treatment of chronic hepatiti

Interferon treatment of chronic hepatitis C

✍ Gary L. Davis 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 801 KB

Impact of obesity on treatment of chroni

Impact of obesity on treatment of chronic hepatitis C

✍ Michael R. Charlton; Paul J. Pockros; Stephen A. Harrison 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

Obesity and the metabolic syndrome have hepatic manifestations, including steatosis and progression of fibrosis. In individuals with chronic hepatitis C, obesity is associated with inflammation, insulin resistance, steatosis, progression of fibrosis, and nonresponse to treatment with interferon or p